Right to Try Act - Expanding Access to Experimental Brain Tumor Treatments

This U.S. law allows brain tumor patients access to experimental treatments not yet approved by the U.S Food and Drug Administration (FDA). Watch this American Brain Tumor Association's Educational Webinar, "Right to Try & Expanded Access - What to Know" to learn more about on the benefits and limitations of this law and expanded access.

This webinar is presented by Kevin Weatherwax, CCRC, CCRA, Managing Director of the Michigan Institute for Clinical & Health Research and Co-chair of the Michigan Medicine Expanded Access Oversight Committee.

Webinar Overview:
• Understand the patient’s rights in treatment decisions and clinical trials
• Learn about the benefits and risks of expanded access and right to try laws
• Considerations when talking about investigational therapies and clinical trials with your provider

The ABTA educational webinars are designed for brain tumor patients and caregivers to learn more about brain tumor types, treatments and research. Webinars are 60 minutes and free to all who are interested. To learn about upcoming webinars, visit https://bit.ly/3xev6HE.

For more information or additional resources, contact the American Brain Tumor Association at (800) 886-2282, info@abta.org or visit https://www.abta.org/.

Видео Right to Try Act - Expanding Access to Experimental Brain Tumor Treatments канала American Brain Tumor Association